The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 55 | — | 20.1x | Near average | |
Growth | 42 | 29.1% | 5.6% | Near average | |
Quality | 32 | -78.9% | 7.6% | Below average | |
Safety | 43 | -1.6x | 0.4x | Near average | |
Capital Return | 20 | — | 2.19% | Below average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Biodesix, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Biodesix, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Biodesix stock shows a state of extreme uncertainty and a wide gap in analyst estimates, as the current price (14.93) trades significantly higher than the average price target (8.67). We observe a sharp dispersion between the high of 20 and the low of 3, reflecting a lack of consensus on the stock's fair value given that only one analyst covers the recent data, which reduces the statistical reliability of the forecasts.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.